- Trials with a EudraCT protocol (2,423)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,423 result(s) found for: Medical tests.
Displaying page 1 of 122.
EudraCT Number: 2011-001221-24 | Sponsor Protocol Number: 01/2011tk | Start Date*: 2012-01-05 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Specific immunotherapy of birch pollen-related food allergy | ||
Medical condition: Allergy to apple in birch pollen allergic patients | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001801-42 | Sponsor Protocol Number: EPU-P76 | Start Date*: 2014-11-25 |
Sponsor Name:Maastricht University | ||
Full Title: Sensitivity of driving-related psychometric tests to the effects of two widely prescribed benzodiazepines: diazepam and oxazepam | ||
Medical condition: None | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006217-25 | Sponsor Protocol Number: LIMON | Start Date*: 2007-04-05 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: Utilizzo intraoperatorio del verde indocianina-pulsion quale test predittivo di insufficienza epatica dopo resezione epatica maggiore | |||||||||||||
Medical condition: Pazienti con neoplasie epatiche con indicazione chirurgica | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000593-29 | Sponsor Protocol Number: CHUBX2020/64 | Start Date*: 2021-06-17 |
Sponsor Name:CHU DE BORDEAUX | ||
Full Title: A Prospective Pilot Study to assess the efficacy of BOTOX-A in patients with Low Anterior Resection syndrome (LARS>20) and refractory medical treatment after rectal resection | ||
Medical condition: Low Anterior Resection syndrome (LARS>20) and refractory medical treatment after rectal resection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001456-34 | Sponsor Protocol Number: ArgatrobanECMO_1.2 | Start Date*: 2021-07-08 |
Sponsor Name:Medical University of Vienna | ||
Full Title: A prospective randomized pilot trial on safety and feasibility of Argatroban as anticoagulant in patients with extracorporeal membrane oxygenation (ECMO) | ||
Medical condition: patients requiring treatment with extracorporeal membrane oxygenation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2007-004772-39 | Sponsor Protocol Number: LYSINE1 | Start Date*: 2007-12-19 |
Sponsor Name:Sahlgrenska Acadademy, GU | ||
Full Title: AN EXPLORATORY OPEN LABEL STUDY OF ADJUNCTIVE L-LYSINE TREATMENT IN PATIENTS WITH SCHIZOPHRENIA | ||
Medical condition: Schizophrenia and related psychoses | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003956-30 | Sponsor Protocol Number: CHDR1429 | Start Date*: 2014-10-13 |
Sponsor Name:Centre for Human Drug Research | ||
Full Title: A single-centre randomized double-blind, double-dummy, placebo-controlled, four-way crossover study in healthy subjects to investigate the effect of ethanol 0.5 and 1.0 g/L and alprazolam 1 mg on a... | ||
Medical condition: A total of 24 healthy subjects, both male and female, will be enrolled into the study following satisfactory completion of a screening visit where eligibility for the study will be checked. Subje... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019767-11 | Sponsor Protocol Number: Ö-PKU1 | Start Date*: 2010-09-08 |
Sponsor Name:Graz Medical University | ||
Full Title: Ö-PKU 1 – Evaluation of a Test for the identication of BH4 responsive PKU patients | ||
Medical condition: Hyperphenylalaninaemia (HPA) in adult and paediatric patients of 4 years of age and over with phenylketonuria (PKU). | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000992-26 | Sponsor Protocol Number: VAPOR002 | Start Date*: 2016-06-29 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Volatile Anesthetic Protection Of Renal transplants 2 | ||
Medical condition: kidney transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) DK (Completed) ES (Completed) NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001443-31 | Sponsor Protocol Number: 1801 | Start Date*: 2018-11-21 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: DOAC Levels prior to Incision study: DALI study | ||
Medical condition: No medical condition will be investigated. This study will only investigate DOAC levels during surgery. Patients who use DOACs are patients with venous thrombosis and atrial fibrillation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004305-25 | Sponsor Protocol Number: EPU P25 | Start Date*: 2006-09-15 |
Sponsor Name:Maastricht University | ||
Full Title: Residual effects of zopiclone 7.5 mg and temazepam 20 mg on cognition and actual driving performance in healthy elderly | ||
Medical condition: Healthy elderly volunteers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005619-16 | Sponsor Protocol Number: | Start Date*: 2009-10-07 | |||||||||||
Sponsor Name:Erasmus Medical Center | |||||||||||||
Full Title: Impact of anti-tumor necrosis factors antibodies treatment on fertility of inflammatory bowel diseases male patients | |||||||||||||
Medical condition: Fertility influenced by antiTNF treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003566-13 | Sponsor Protocol Number: GLP1-hypofyse | Start Date*: 2019-01-02 |
Sponsor Name:Radboud university medical center | ||
Full Title: iPAVE – imaging Pituitary ActiVation by Exendin | ||
Medical condition: Type 2 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002077-76 | Sponsor Protocol Number: QGUY/2005/AER 001/-02 | Start Date*: 2005-06-13 |
Sponsor Name:Aerovance Inc | ||
Full Title: A Phase 2a Study To Investigate The Effects of Repeated Administration of AeroDerm in subjects with Atopic Eczema. | ||
Medical condition: Atopic Eczema: a chronic inflammatory pruritic skin disease that follows a relapsing course and is often associated with elevated serum immunoglobulin E (IgE) levels and a personal or family histor... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001042-24 | Sponsor Protocol Number: INFQ3001 | Start Date*: 2015-05-27 | |||||||||||||||||||||
Sponsor Name:Abbott Biologicals B.V. | |||||||||||||||||||||||
Full Title: Randomized, Double-Blind, Active-Controlled Study in Adults to Assess the Safety and Immunogenicity of Abbott’s Candidate Quadrivalent Influenza Vaccine and its Non-Inferiority to Trivalent Influen... | |||||||||||||||||||||||
Medical condition: Prophylaxis of Influenza | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) LV (Completed) HU (Completed) LT (Completed) BE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003763-22 | Sponsor Protocol Number: 1.027.19 | Start Date*: 2020-01-23 | |||||||||||
Sponsor Name:Tayside Medical Sciences Centre on behalf of University of Dundee & NHS Tayside | |||||||||||||
Full Title: A Pragmatic Proof of Concept Study to Evaluate the Effect of Benralizumab on Mannitol Challenge in Severe Eosinophilic Asthma | |||||||||||||
Medical condition: Severe Eosinophilic Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005015-17 | Sponsor Protocol Number: GE09-01 | Start Date*: 2009-05-13 |
Sponsor Name:VU university medical centre | ||
Full Title: Effect of N-acetylcysteine on thiopurine related hepatotoxicity in IBD patients | ||
Medical condition: adult patients (18-70 years old) who have been treated with azathioprine, 6-mercaptopure or 6-thioguanine for inflammatory bowel disease, in whom hepatotoxicity occured as an adverse event, are eli... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003029-11 | Sponsor Protocol Number: 2012-489 | Start Date*: 2012-09-10 | ||||||||||||||||
Sponsor Name:Steen Stender | ||||||||||||||||||
Full Title: Ethyl ester Versus Triglyceride formulations of long chained omega-3 fatty acids in moderate hypertriglyceridemia - a randomized placebo-controlled clinical trial (EVT) | ||||||||||||||||||
Medical condition: Hypertriglyceridemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-005282-37 | Sponsor Protocol Number: IDT.LM.LEV.22004-LEMDE | Start Date*: 2005-05-24 |
Sponsor Name:QUIMICA FARMACEUTICA BAYER, S.A. | ||
Full Title: Double-blind, cross-over, placebo-controlled pilot study to characterize the profile of those patients with traumatic spinal cord injury diagnosed by electrophysiological, urodynamic and clinical (... | ||
Medical condition: Erectile dysfunction (ED) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005417-13 | Sponsor Protocol Number: 13-HMedIdeS-02 | Start Date*: 2014-04-24 |
Sponsor Name:Hansa Medical AB [...] | ||
Full Title: A PHASE II STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF INTRAVENOUS IDES AFTER ADMINISTRATION OF ASCENDING DOSES IN CHRONIC KIDNEY DISEASE PATIENTS | ||
Medical condition: Chronic kidney disease (CKD) stage 5 and on waiting list for renal transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
